ArticleObesity surgery2025
Long-Term Outcomes of Single and Dual Anastomosis Duodenal Switch.
Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Five-year outcomes of two duodenal switch variants: BPD/DS vs. SADI-S.Surgical endoscopy · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundSingle anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S) offers a streamlined alternative to biliopancreatic diversion with duodenal switch (BPD/DS), potentially with a lower risk of complications in patients with obesity grade III, although long-term comparative studies are lacking. PURPOSE: To compare long-term outcomes of patients undergoing SADI-S and BPD/DS.
methodsA cohort of 114 patients with a body mass index (BMI) equal to or greater than 45 kg/m
resultsAfter ≥ 60 months of follow-up, patients submitted to BPD/DS and SADI-S achieved a total weight loss (TWL) > 20% (96% vs 91%, p = 0.67) and similar remission rates of associated medical problems. Transient vitamin and micronutrient deficiencies during follow-up were observed in 44.8% of BPD/DS patients and 63.5% of SADI-S patients, anemia in 44.8% and 42.4%, and iron deficiency in 58.6% and 48.2%, respectively. Quality of life (QoL) scores were not significantly different between the groups (BPD/DS: 2.00 ± 0.22 vs. SADI-S: 2.15 ± 0.19, p = 0.08). After propensity score matching (n = 28 per group), differences in weight loss outcomes became more pronounced, favoring BPD/DS, while SADI-S was associated with significantly greater improvement in quality-of-life.
conclusionsThe long-term outcomes of BPD/DS and SADI-S in terms of obesity-related comorbidities remission and complication rates do not seem to differ, despite BPD/DS inducing greater weight loss and SADI-S being associated with greater improvements in quality of life.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.